European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading

European equities traded in the US as American depositary receipts were tracking lower late Thursday morning, declining 0.47% to 1,438.05 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by internet ad company Criteo (CRTO) and biotech firm Evaxion Biotech (EVAX), which rose 2.7% and 2.4%, respectively. They were followed by telecommunications company Ericsson (ERIC) and pharmaceutical company Novo Nordisk (NVO), which were up 0.4% and 0.2%, respectively.

The decliners from continental Europe were led by biopharmaceutical company Cellectis (CLLS) and financial services company Banco Santander (SAN), which fell 4.2% and 3.8%, respectively. They were followed by financial services company Banco Bilbao Vizcaya Argentaria (BBVA) and accommodations booking site trivago (TRVG), which dropped 3.2% and 3%, respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies NuCana (NCNA) and TC Biopharm (TCBP), which advanced 5.9% and 4.9%, respectively. They were followed by biopharmaceutical company Akari Therapeutics (AKTX) and biotech firm Trinity Biotech (TRIB), which increased 3% and 2.7%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Adaptimmune Therapeutics (ADAP) and Biodexa Pharmaceuticals (BDRX), which tumbled 23% and 12%, respectively. They were followed by education company Pearson (PSO) and financial services company HSBC (HSBC), which were down 5% and 2.5%, respectively.